Solara Active Pharma Sciences inks pact with SeQuent Scientific

24 Sep 2018 Evaluate

Solara Active Pharma Sciences has entered into a business transfer agreement with SeQuent Scientific for sale of API facility at Mahad. The total consideration for the unit would be Rs 46.40 crore. The company has decided to hive-off Mahad unit as it is not aligned to multi product and US focused business of the company.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.